Empery Asset Management, LP Codiak Bio Sciences, Inc. Transaction History

Empery Asset Management, LP

  • $16.8 Million
  • Q3 2022

A detailed history of Empery Asset Management, LP transactions in Codiak Bio Sciences, Inc. stock. As of the latest transaction made, Empery Asset Management, LP holds 237,943 shares of CDAK stock, worth $2,379. This represents 1.11% of its overall portfolio holdings.

Number of Shares
237,943
Holding current value
$2,379
% of portfolio
1.11%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.82 - $3.19 $195,113 - $759,038
237,943 New
237,943 $186,000

Others Institutions Holding CDAK

# of Institutions
1
Shares Held
238K
Call Options Held
0
Put Options Held
0
View Full List

About Codiak BioSciences, Inc.

CDAK Quotes by TradingView
  • Ticker CDAK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,995,200
  • Market Cap $360K
  • Description
  • Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...
More about CDAK
Track This Portfolio

Track Empery Asset Management, LP Portfolio

Follow Empery Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empery Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Empery Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email